Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.
What? HONOR X7d for just one peso this 11.11! Global AI device ecosystem company HONOR Philippines just recently launched its all-new HONOR X7d, and now ...
Vertex Pharmaceuticals Incorporated today announced updated data for povetacicept (pove) in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) from the ongoing RUBY-3 trial at the ...
Synthekine Inc., an engineered cytokine therapeutics company, today announced positive initial results from a Phase 1a/1b clinical trial of STK-012 in first-line, PD-L1 negative nonsquamous (NSQ) ...
Treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone lymphoma, motion sickness, ...
This study provides a valuable genome-centric characterization of microbial communities across deep sediment cores from a Spartina patens salt marsh. The study provides claims on the metabolic ...
Operator: Greetings, and welcome to the Longeveron 2025 Q3 Financial Results and Business Update Call. [Operator Instructions ...
Maritime Security and the Blue Economy amid Winds and Waves The post-war reconfiguration of Sri Lanka’s foreign policy ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the Phase 3 ASCENT-07 study investigating Trodelvy® (sacituzumab ...
Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...
Discover the best home-improvement products—lab-tested, expert-approved upgrades for kitchens, baths, and beyond from Good ...
Total Revenue -- $86,000 was recognized in the third quarter from initial sales of nPulse Capital and Vibrance disposables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback